Song Biotechnologies, LLC

07/17/2025

This paper in SHOCK was accepted in February, and was available in pre-press, but this week the final version was uploaded.

This work compared a PEG-HBOC against autologous whole blood, fresh pooled plasma and Lactated Ringers'.

Thanks to the co-authors: Vandegriff, Sheppard, Malavalli and Nugent.

rs (HBOCs) are designed to relieve the hypoperfusion and hypoxia of shock during the critical pre-hospital period. A new PEGylated human HBOC product, VS-101, with high oxygen affinity and hyperoncotic pressure, has been designed for hypovolemic resuscitation protocols at the point of injury. Thirty...

05/05/2025

CTTACC 2025. Setup and ready for The conference. Proud to be part of this.

02/28/2025

A novel way of differentiating oxygen supply and demand in young vs old skeletal muscle.

Thank you to the collaborators Drs. Nugent, Golub and Pittman!

Muscle function declines with age. Since the primary energy source for contraction is aerobic, this study investigated age-related changes in muscle oxygenation dynamics to: characterize PO2 transien...

01/10/2025

Starting off the year with another peer-reviewed journal. Showcasing our interstitial oxygenation technique in various age groups.

Would like to thank Drs. Nugent, Golub and Pittman!

Human populations are experiencing unprecedented growth and longevity with lingering knowledge gaps of the characteristics, mechanisms, and pathologies of senescence. Invasive measurements and long-term control conditions for longitudinal studies are infeasible, necessitating the need for surrogate....

01/02/2025

This year marks the 10th anniversary of Song Biotechnologies.

We have been very fortunate to see continued growth despite shifts in the financial climate. To date, we have published over 15 peer-reviewed articles, successfully been part of over 10 BAA and SBIR grants, and have had the privilege of being part of the development and/or evaluation of exclusive novel technologies. These include potentially life-saving resuscitation fluids, transdermal drug delivery systems, devices that can detect pathogens non-invasively and drugs that will reduce systemic inflammation. With this momentum, we are excited to see what 2025 will bring.

11/15/2024

We are setup and ready for The 19th International Symposium on Blood Substitutes (ISBS). www.isbs2024.org

Thankful to be a sponsor. We appreciate the support and exposure.

10/30/2024

Almost 10 months late (ooops), but here's a link to a "recent" publication we published. Special thanks to all of the co-authors: Drs Bruce and Nugent, and D. Carr.

Acute respiratory distress syndrome (ARDS) is a complication of pulmonary disease that produces life-threatening hypoxaemia. Despite ventilation and hyperoxic therapies, undetected hypoxia can mani...

07/16/2024

Pleased to announce that we will give several talks at the upcoming 19th International Symposium on Blood Substitutes (ISBS 2024).

This year it will be held at the Ga***rd National Resort (National Harbor, MD). NOVEMBER 14-18.

The 19th International Symposium on Blood Substitutes (ISBS) in 2024 in National Harbor, Maryland, at the gateway to Washington, DC, will champion a time honored tradition of biannual meetings held alternatively in Asia, North America and Europe, to highlight the advances in the science and developm...